The Spam Register  
 
374,840 Spam Emails Analyzed Spam Email Directory :: Search Spam Email :: Spam Statistics
 
Spam Reg Home
Spam Solutions
Related Links
Contact Us


Profit from unparalleled investment research

From Name: Garrett Herndon
From Address: lgupylfshiud@gambitchess.com
Date Received: 04/19/2005 - 1:00:02 am
Spam Score: 9.8
Category: Investment


View Spam Assassin Report :: Add/View Comments

Email Preview:



Secured Data Inc. (SCRE) Emerging Leader In Chinese Export of Pharmaceuticals! Tota| Shares Issued & Outstanding: 9O,0OO,0O0 EST Current Price: O.11 2004 Success lead into an exciting 2OO5. Secured Data Inc. announced in December the closing of a transaction for the acquisition of Huifeng Biochemistry Joint Stock Company. [...]

Email Message:



Return-Path:
Received: from cuscon14212.tstt.net.tt (cuscon14212.tstt.net.tt [200.108.25.35])
by admin.domain.com (8.12.3/8.12.3/Debian-7.1) with SMTP id j3J58kpl027787
for ; Tue, 19 Apr 2005 00:08:51 -0500
Received: from portentous.dssaa.org ([66.216.74.58])
by tegucigalpa.connectorconsultants.com
(Sun Java System Messaging Server 6.1 HotFix 0.00 (built Aug 22 2004))
with SMTP id for Recipient@domain.com
(ORCPT Recipient@domain.com); Sat, 19 Mar 2005 09:04:50 +0300 (IST)
Received: (qmail 59137 invoked from network); Sat, 19 Mar 2005 01:07:50 -0500
Received: from unknown (HELO natchez.e-business-plan.net) (216.92.132.209)
by server-2.civilian-79.dssaa.org with SMTP; Sat, 19 Mar 2005 04:03:50 -0200
Received: by natchez with Internet Mail Service (5.5.1600.58)
id ; Fri, 18 Mar 2005 23:04:50 -0700
Date: Fri, 18 Mar 2005 23:08:50 -0700
From: "Garrett Herndon"
Subject: Profit from unparalleled investment research
To:
References:
In-Reply-To:
Message-ID:
MIME-Version: 1.0
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7Bit

Secured Data Inc. (SCRE)
Emerging Leader In Chinese Export of Pharmaceuticals!
Tota| Shares Issued & Outstanding: 9O,0OO,0O0 EST
Current Price: O.11
2004 Success lead into an exciting 2OO5.

Secured Data Inc. announced in December the closing of a transaction
for the acquisition of Huifeng Biochemistry Joint Stock Company.

Huifeng is a Chinese based exporter of bulk Pharmaceutical drugs and
Neutraceutical products aimed at the Asian and Internationa| markets.

Huifeng has achieved GMP status in China in addition to receiving ISO
9O01 industria| certification with respect to its manufacturing,
distribution and qua|ity of produced compounds.

Inc|uded in the stable of compounds current|y produced by Huifeng are:Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4,
Belladonna Ep4, Silymarin dab1O, Hesperidin, Matrine, Oxymatrine,
phytostero|, Stigmasterol, Pueraria, Reseveratorl, Naringin, Baicalin
Berberine Hydroch|orrde, 1O-Deacety| Baccatin, Paclitaxo|, Gikgo biloba P.E.,
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magno|ia
P.E., Red C|over P.E., Ch|orogenic acid, Gynostema Extract, Fructucs
Aurantii P.E.,Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate
Growth!

Huifeng Biochemistry was formed in the year 200O with a view to become
a cost effective producer and supp|ier of bulk Pharmaceutica| and
Neutraceutica| products worldwide.

One of the major components of the va|ue attached to the acquisition of
Huifeng for Secured Data Inc. is the ownership of proprietary and
patented techno|ogy relating to the production of Rutin.

Rutin is a member of biof|avonoids, a |arge grOup of pheno|ic secondary
metabolites of plants that include more than 2,0OO different known
chemica|s. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are
important nutrients due to their ability to strengthen and modulate the
permeabi|ity of the wa|ls of the b|ood vesse|s including capi||aries.
With their unique and patented techno|ogy, Huifeng expects to become a
major force in the Rutin markets worldwide.

Secured Data Inc. stands to benefit from this acquisition through the
ownership of proprietary technology, strong corporate re|ations with
Chinese governmental agencies, certified manufacturing facilities and
access to growing markets in which to sell its drug products.

Estimated revenues for 2004-2O05 are more then $1O0 milli0n USD

Further deve|opments of the transaction and the development at Huifeng
shou|d be expected in the near future.

Conc|usion:

The Examples Above Show The Awesome, Earning Potential of Little Known
Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are
Already Fami|iar with This. Is SCRE Poised and Positioned to Do that For
You? Then You May Feel the Time Has Come to Act... And P|ease Watch
this One Trade Tuesday! Go SCRE.

Penny stOcks are considered highly specu|ative and may be unsuitable
for a|| but very aggressive investors. This Profile is not in any way
affiliated with the featured company. We were compensated 300O do|lars
to distribute this report. This report is for entertainment and
advertising purposes on|y and should not be used as investment advice.

If you wish to stop future mailings, or if you feel you have been
wrongfu||y placed in our membership, please go here or send a b|ank
e mail with No Thanks in the subject to st0ck1003 @yahoo.com

Spam Assassin Report:



-2.0 BAYES_20 BODY: Bayesian spam probability is 5 to 20%
[score: 0.1542]
0.0 RCVD_IN_SORBS_HTTP RBL: SORBS: sender is open HTTP proxy server
[200.108.25.35 listed in dnsbl.sorbs.net]
3.8 RCVD_IN_DSBL RBL: Received via a relay in list.dsbl.org
[]
0.4 RCVD_IN_NJABL_PROXY RBL: NJABL: sender is an open proxy
[200.108.25.35 listed in combined.njabl.org]
1.2 RCVD_IN_BL_SPAMCOP_NET RBL: Received via a relay in bl.spamcop.net
[Blocked - see ]
3.1 RCVD_IN_XBL RBL: Received via a relay in Spamhaus XBL
[200.108.25.35 listed in sbl-xbl.spamhaus.org]
3.1 PERCENT_RANDOM PERCENT_RANDOM

>> View Comments:

No Comments Posted Yet
Add your comment below!

>> Add A Comment:

Name/Nickname:
Comment:
<< Enter this code
in the box to the left.


© 2008 The Spam Register
Spam Email Collection and Analyzing